news
& events

July 28, 2017

UE Decision n. 2017/1387 - authorising the placing on the market of an enzyme preparation of prolyl oligopeptidase produced with a genetically modified strain of Aspergillus niger as a novel food ingredient

The European Commission, with EU Decision of 24 July 2017 no. 1387, authorized the use of the enzymatic preparation of prolylglyptopeptidase produced by a genetically modified strain of Aspergillus niger in food supplements intended for the adult population in general under the rules governing new products and novel food ingredients.

Provisions provided for in EU Decision no. 2017/1387

The EU Decision in question authorizes the use of the enzymatic preparation of proliloligopeptidase produced by a genetically modified strain of Aspergillus niger in food supplements for the adult population in general, with a maximum dose not exceeding 120 PPU / day (2 , 7 g of enzyme preparation per day) (2 × 106 PPI / day).

Finally, the ingredient in question to be marketed in the territory of the European Union must comply with the technical specifications set out in the Annex to that Decision.

Indication to be reported on the label of food supplements

The authorized name to be included in the labeling of food supplements containing the enzymatic preparation of proliloligopeptidase produced with a genetically modified strain of Aspergillus niger is "proliloligopeptidase".